GEN News: Drug promotes nervous system repair in animal models of stroke
Genetic Engineering & Biotechnology News recently featured research from the University of Cincinnati's Agnes (Yu) Luo, PhD.
Luo and her colleagues recently published a preclinical study in the journal Cell Reports showing a new drug may help repair damage caused by strokes. The drug was shown to be effective at repairing the nervous system in animal models of stroke.
“We are very excited about the data showing significant improvement in motor function, sensory function, spatial learning, and memory, even when treatment was initiated as late as seven days after stroke onset,” said Luo, associate professor in the Department of Molecular Genetics and Biochemistry in UC’s College of Medicine and the study’s senior author.
There are currently no FDA approved drugs to repair damage caused by a stroke, and Luo said the drug would be a “substantial breakthrough” if the early results translate into clinical settings.
Read more about Luo's research.
Featured photo at top courtesy of Unsplash.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.